LCM
KNSA icon

Landscape Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Landscape Capital Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,492
Closed -$939K – 781
2026
Q1 		$939K Buy
+19,492
New +$863K 0.06% 399
2021
Q1 		– Sell
-26,682
Closed -$471K – 502
2020
Q4 		$471K Sell
26,682
-17,694
-40% -$311K 0.07% 238
2020
Q3 		$680K Hold
44,376
– – 0.12% 145
2020
Q2 		$1.13M Buy
+44,376
New +$927K 0.19% 123

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Landscape Capital Management's KNSA Position: Q2 2026 in Review

Landscape Capital Management sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2026, closing a stake of 19,492 shares — an estimated $939K sold.

Landscape Capital Management first reported a position in KNSA in Q2 2020 and held it in 4 quarters. The position peaked at $1.13M in Q2 2020. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Landscape Capital Management reported no remaining Kiniksa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Landscape Capital Management sold 19,492 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $939K.
  • Landscape Capital Management first reported a position in Kiniksa Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Landscape Capital Management's Kiniksa Pharmaceuticals position peaked at $1.13M in Q2 2020.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.